Robin Carhart-Harris, PhD
Professor
Neurology
School of Medicine

Websites

Show all (3) Hide

• Support Dr Carhart-Harris' Research (makeagift.ucsf.edu)
• Carhart-Harris Lab (carhartharrislab.com)
• Posts on X @RCarhartHarris (X.com)

Publications (270)

Top publication keywords:
Depressive Disorder, Treatment-ResistantConsciousnessReceptor, Serotonin, 5-HT2ALysergic Acid DiethylamideAntidepressive AgentsEgoMusicHallucinogensEmotionsSerotonin 5-HT2 Receptor AgonistsPsilocybinBrainN,N-DimethyltryptamineN-Methyl-3,4-methylenedioxyamphetamineConnectome

• Human brain changes after first psilocybin use.
  Nature communications 2026 Lyons T, Spriggs M, Kerkelä L, Rosas FE, Roseman L, Mediano PAM, Timmermann C, Oestreich L, Pagni BA, Zeifman RJ, Hampshire A, Trender W, Douglass HM, Girn M, Godfrey K, Kettner H, Sharif F, Espasiano…
• Effects of psychedelic use on authoritarian attitudes revisited.
  Journal of psychopharmacology (Oxford, England) 2026 Simonsson O, Lyons T, Marks J, Kettner H, Roseman L, Haijen E, Kaelen M, Carhart-Harris R
• An international mega-analysis of psychedelic drug effects on brain circuit function.
  Nature medicine 2026 Girn M, Doss MK, Roseman L, Preller KH, Palhano-Fontes F, Pasquini L, Barrett FS, Mallaroni P, Mason NL, Timmermann C, McCulloch DE, Fisher PM, Winston BS, Moujaes F, Muller F, Liechti ME, …
• The role of therapeutic alliance in psilocybin treatment for treatment-resistant depression: A post hoc path analysis.
  Journal of affective disorders 2026 Goodwin GM, Aaronson ST, Alvarez O, Carhart-Harris R, Croal M, Feifel D, Hellerstein DJ, Husain MI, Kelly JR, Kirlic N, Licht RW, Marwood L, Nowakowska A, Pálenícek T, Repantis D, Schoevers RA, …
• Detecting neuroplastic effects induced by ketamine in healthy human subjects: A multimodal approach.
  Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism 2026 Agnorelli C, Peill J, Sawicka G, Kurtin D, Shatalina E, Ahmad K, Wall MB, Rua C, Godfrey K, Ertl N, Searle G, Zhou K, Osugo M, Weiss B, Greenway KT, Fagiolini A, Carhart-Harris R, Matthews PM, Rabiner…

Show all (265 more) Hide

• The combination of exercise and psychedelics for the treatment of major depressive disorder.
  Discover mental health 2026 Fabiano N, Stubbs B, Lawrence DW, Rosenblat JD, Teixeira PJ, Wong S, Zhou C, Carhart-Harris R
• Baseline Mood and "Relational Triad" Predict Acute Qualities of Psychedelic Experience.
  Behavioral sciences (Basel, Switzerland) 2026 Lipson J, Kettner H, Carhart-Harris R, Miller L
• A short-acting psychedelic intervention for major depressive disorder: a phase IIa randomized placebo-controlled trial.
  Nature medicine 2026 Erritzoe D, Barba T, Benway T, Joel Z, Good M, Layzell M, Jones MB, Campbell G, Murphy-Beiner A, Rands P, Boyce M, Topping H, Weiss B, Timmermann C, Nutt D, Carhart-Harris R, Routledge C, James E
• The science of psychedelic medicine.
  Nature medicine 2026 Siegel JS, Liston C, Nicol GE, Carhart-Harris RL, Bogenschutz MP
• DMT-Induced Shifts in Criticality Correlate with Self-Dissolution.
  The Journal of neuroscience : the official journal of the Society for Neuroscience 2026 Irrmischer M, Aqil M, Luan L, Wang T, Engelbregt H, Carhart-Harris R, Linkenkaer-Hansen K, Timmermann C
• Blunted Psychedelic Drug Effects in Older Adults.
  The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry 2026 Aday JS, Carhart-Harris RL, Boehnke KF
• Thresholding and Perfusion Considerations in Interpreting Reduced Brain Responsiveness With Escitalopram: Response to Knudsen et al.
  The American journal of psychiatry 2026 Wall MB, Demetriou L, Giribaldi B, Roseman L, Ertl N, Erritzoe D, Nutt DJ, Carhart-Harris RL
• Correction: Short- and long-term modulation of rat prefrontal cortical activity following single doses of psilocybin.
  Molecular psychiatry 2025 Purple RJ, Gupta R, Thomas CW, Golden CT, Palomero-Gallagher N, Carhart-Harris R, Froudist-Walsh S, Jones MW
• "Awe-scillations": EEG spectral and complexity representations of awe.
  bioRxiv : the preprint server for biology 2025 Chen JC, Mace G, Ostrand A, Valtierra C, Griffith S, Campusano R, Li A, Vinson E, Schlomberg JT, Eshel M, Suntay JM, Rahim S, Anguera R, Brown DA, Swann NC, Mazzucato L, Hu X, Zhang D, Timmermann C, …
• A Virtual Clinical Trial of Psychedelics to Treat Patients With Disorders of Consciousness.
  Advanced science (Weinheim, Baden-Wurttemberg, Germany) 2025 Alnagger NLN, Cardone P, Martial C, Perl YS, Mindlin I, Sitt JD, Roseman L, Carhart-Harris R, Nutt D, Mallaroni P, Mason N, Ramaekers JG, Bonhomme V, Laureys S, Deco G, Gosseries O, Núñez P, Annen J
• Correction: Synergistic, multi-level understanding of psychedelics: three systematic reviews and meta-analyses of their pharmacology, neuroimaging and phenomenology.
  Translational psychiatry 2025 Shinozuka K, Jerotic K, Mediano P, Zhao AT, Preller KH, Carhart-Harris R, Kringelbach ML
• Negative affective bias in depression following treatment with psilocybin or escitalopram - a secondary analysis from a randomized trial.
  Translational psychiatry 2025 Martens MAG, Cunha BG, Erritzoe D, Nutt D, Carhart-Harris R, Harmer CJ
• Efficacy, all-cause discontinuation, and safety of serotonergic psychedelics and MDMA to treat mental disorders: A living systematic review with meta-analysis.
  European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 2025 Højlund M, Kafali HY, Kirmizi B, Fusar-Poli P, Correll CU, Cortese S, Sabé M, Fiedorowicz J, Saraf G, Zein J, Berk M, Husain MI, Rosenblat JD, Rubaiyat R, Corace K, Wong S, Hatcher S, Kaluzienski M, …
• Null models for comparing information decomposition across complex systems.
  PLoS computational biology 2025 Liardi A, Rosas FE, Carhart-Harris RL, Blackburne G, Bor D, Mediano PAM
• Dissociable effects of LSD and MDMA on striato-cortical connectivity in healthy subjects.
  Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 2025 Ertl N, Ashraf I, Azizi L, Roseman L, Erritzoe D, Nutt DJ, Carhart-Harris RL, Wall MB
• Eigenmodes of the deep unconscious: the neuropsychology of Jungian archetypes and psychedelic experience.
  Neuroscience of consciousness 2025 McGovern H, Aqil M, Atasoy S, Carhart-Harris R
• Corrigendum to "The role of the psychedelic experience in psilocybin treatment for treatment-resistant depression" [Journal of Affective Disorders, Volume 372 (2025), Pages 523-532].
  Journal of affective disorders 2025 Goodwin GM, Aaronson ST, Alvarez O, Carhart-Harris R, Chai-Rees J, Croal M, DeBattista C, Dunlop BW, Feifel D, Hellerstein DJ, Husain MI, Kelly JR, Kirlic N, Licht RW, Marwood L, Meyer TD, Mistry S, …
• Cross-species mapping of psychedelic gene expression reveals links to the 5HT2A receptor, cortical layers, and human accelerated regions.
  Research square 2025 Pasquini L, McConnell P, Raffety J, Li A, Steinberg E, Rahim S, Valtierra C, Gazzaley A, Carhart-Harris R
• Toward a unified taxonomy of information dynamics via Integrated Information Decomposition.
  Proceedings of the National Academy of Sciences of the United States of America 2025 Mediano PAM, Rosas FE, Luppi AI, Carhart-Harris RL, Bor D, Seth AK, Barrett AB
• N,N-dimethyltryptamine effects on connectome harmonics, subjective experience and comparative psychedelic experiences.
  Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 2025 Vohryzek J, Luppi AI, Atasoy S, Deco G, Carhart-Harris RL, Timmermann C, Kringelbach ML
• Exploring the potential psychological predictors associated with changes in depression, anxiety, and well-being following naturalistic psychedelic use.
  Journal of psychiatric research 2025 Herrmann FM, Jones G, Low DM, Zech JM, Carhart-Harris RL, Kettner H
• Short- and long-term modulation of rat prefrontal cortical activity following single doses of psilocybin.
  Molecular psychiatry 2025 Purple RJ, Gupta R, Thomas CW, Golden CT, Palomero-Gallagher N, Carhart-Harris R, Froudist-Walsh S, Jones MW
• Validation of the Imperial Psychedelic Predictor Scale - CORRIGENDUM.
  Psychological medicine 2025 Angyus M, Osborn S, Haijen E, Erritzoe D, Peill J, Lyons T, Kettner H, Carhart-Harris R
• Psychedelic Therapy, Positive Emotional Experiences, and the Central Role of Self-Compassion.
  Research square 2025 Zeifman R, Danias G, Agin-Liebes G, Pagni B, Kettner H, Bhat V, Ross S, Erritzoe D, Carhart-Harris R
• Improved mental health outcomes and normalised spontaneous EEG activity in veterans reporting a history of traumatic brain injuries following participation in a psilocybin retreat.
  Frontiers in psychiatry 2025 Blest-Hopley G, Pasculli G, Ruffell SGD, Tsang W, Emmanuel O, Pate KM, Kettner H, Roseman L, Erritzoe D, Carhart-Harris R
• Perturbing whole-brain models of brain hierarchy: An application for depression following pharmacological treatment.
  Annals of the New York Academy of Sciences 2025 Socoró-Garrigosa M, Perl YS, Kringelbach ML, Erritzoe D, Nutt DJ, Carhart-Harris R, Vohryzek J, Deco G
• Correction: Dissociable effects of psilocybin and escitalopram for depression on processing of musical surprises.
  Molecular psychiatry 2025 Harding R, Singer N, Wall MB, Hendler T, Erritzoe D, Nutt D, Carhart-Harris R, Roseman L
• Exploring the Therapeutic Effects of Psychedelics Administered to Military Veterans in Naturalistic Retreat Settings.
  Brain and behavior 2025 Calnan M, Blest-Hopley G, Busch C, Adams M, Ruffell SGD, Piper T, Roseman L, Kettner H, Carhart-Harris R
• Single-dose (10 mg) psilocybin reduces symptoms in adults with obsessive-compulsive disorder: A pharmacological challenge study.
  Comprehensive psychiatry 2025 Pellegrini L, Fineberg NA, O'Connor S, De Souza AMFLP, Godfrey K, Reed S, Peill J, Healy M, Rohani-Shukla C, Lee H, Carhart-Harris R, Robbins TW, Nutt D, Erritzoe D
• The effects of psilocybin therapy versus escitalopram on cognitive bias: A secondary analysis of a randomized controlled trial.
  European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 2025 Henry J, Giribaldi B, Nutt DJ, Erritzoe D, Carhart-Harris R, Lyons T
• Enhanced meaning in life following psychedelic use: converging evidence from controlled and naturalistic studies.
  Frontiers in psychology 2025 Roseby W, Kettner H, Roseman L, Spriggs MJ, Lyons T, Peill J, Giribaldi B, Erritzoe D, Nutt DJ, Carhart-Harris RL
• Human neuroimaging: fMRI.
  International review of neurobiology 2025 Wall MB, Carhart-Harris RL
• Reduced Brain Responsiveness to Emotional Stimuli With Escitalopram But Not Psilocybin Therapy for Depression.
  The American journal of psychiatry 2025 Wall MB, Demetriou L, Giribaldi B, Roseman L, Ertl N, Erritzoe D, Nutt DJ, Carhart-Harris RL
• Dissociable effects of psilocybin and escitalopram for depression on processing of musical surprises.
  Molecular psychiatry 2025 Harding R, Singer N, Wall MB, Hendler T, Erritzoe D, Nutt D, Carhart-Harris R, Roseman L
• Prediction of hallucinogen persisting perception disorder and thought disturbance symptoms following psychedelic use.
  PNAS nexus 2025 Zhou K, de Wied D, Carhart-Harris RL, Kettner H
• Exploring 5-MeO-DMT as a pharmacological model for deconstructed consciousness.
  Neuroscience of consciousness 2025 Timmermann C, Sanders JW, Reydellet D, Barba T, Luan LX, Angona ÓS, Ona G, Allocca G, Smith CH, Daily ZG, Mason NL, Kloft-Heller L, Kuchar M, Janeckova L, Palenicek T, Erritzoe D, Ramaekers JG, …
• Network control energy reductions under DMT relate to serotonin receptors, signal diversity, and subjective experience.
  Communications biology 2025 Singleton SP, Timmermann C, Luppi AI, Eckernäs E, Roseman L, Carhart-Harris RL, Kuceyeski A
• Dynamic medial parietal and hippocampal deactivations under DMT relate to sympathetic output and altered sense of time, space, and the self.
  Imaging neuroscience (Cambridge, Mass.) 2025 Pasquini L, Simon AJ, Gallen CL, Kettner H, Roseman L, Gazzaley A, Carhart-Harris RL, Timmermann C
• Decreased CO2 saturation during circular breathwork supports emergence of altered states of consciousness.
  Communications psychology 2025 Havenith MN, Leidenberger M, Brasanac J, Corvacho M, Carmo Figueiredo I, Schwarz L, Uthaug M, Rakusa S, Bernardic M, Vasquez-Mock L, Pérez Rosal S, Carhart-Harris R, Gold SM, Jungaberle H, Jungaberle …
• Neuroplasticity and psychedelics: A comprehensive examination of classic and non-classic compounds in pre and clinical models.
  Neuroscience and biobehavioral reviews 2025 Agnorelli C, Spriggs M, Godfrey K, Sawicka G, Bohl B, Douglass H, Fagiolini A, Parastoo H, Carhart-Harris R, Nutt D, Erritzoe D
• The Role of the Dorsolateral Prefrontal Cortex in Ego Dissolution and Emotional Arousal During the Psychedelic State.
  Human brain mapping 2025 Coleman CR, Shinozuka K, Tromm R, Dipasquale O, Kaelen M, Roseman L, Muthukumaraswamy S, Nutt DJ, Barnett L, Carhart-Harris R
• Exploring serotonergic psychedelics as a treatment for personality disorders.
  Neuropharmacology 2025 Carrithers BM, Roberts DE, Weiss BM, King JD, Carhart-Harris RL, Gordon AR, Pagni BA, Moreau M, Ross S, Zeifman RJ
• Transient destabilization of whole brain dynamics induced by N,N-Dimethyltryptamine (DMT).
  Communications biology 2025 Piccinini JI, Sanz Perl Y, Pallavicini C, Deco G, Kringelbach M, Nutt D, Carhart-Harris R, Timmermann C, Tagliazucchi E
• Psilocybin for disorders of consciousness: A case-report study.
  Clinical neurophysiology : official journal of the International Federation of Clinical Neurophysiology 2025 Cardone P, Núñez P, Alnagger NLN, Martial C, van der Lande GJM, Sandell R, Carhart-Harris R, Gosseries O
• A Field-Wide Review and Analysis of Study Materials Used in Psilocybin Trials: Assessment of Two Decades of Research.
  Psychedelic medicine (New Rochelle, N.Y.) 2025 Yaden DB, Graziosi M, Owen AM, Agin-Liebes G, Aaronson ST, Allen KE, Barrett FS, Bogenschutz MP, Carhart-Harris R, Ching THW, Cosimano MP, Danforth A, Davis AK, Garcia-Romeu A, Griffiths R, Grob CS, …
• Can psychedelic use benefit meditation practice? Examining individual, psychedelic, and meditation-related factors.
  PloS one 2025 Jiwani Z, Goldberg SB, Stroud J, Young J, Curtin J, Dunne JD, Simonsson O, Webb CA, Carhart-Harris R, Schlosser M
• On Minimizing Risk and Harm in the Use of Psychedelics.
  Psychiatric research and clinical practice 2025 Evans J, Aixalà M, Anderson BT, Brennan W, Bremler R, Breeksema JJ, Burback L, Calder AE, Carhart-Harris RL, Cheung K, Devenot N, Gorman I, Gren J, Hendricks PS, Holoyda B, Jacobs E, Krecké J, Kruger …
• A qualitative analysis of the psychedelic mushroom come-up and come-down.
  Npj mental health research 2025 Brouwer A, Brown JK, Erowid E, Erowid F, Thyssen S, Raison CL, Carhart-Harris RL
• Correction: Study Protocol for 'PsilOCD: A Pharmacological Challenge Study Evaluating the Effects of the 5-HT2A Agonist Psilocybin on the Neurocognitive and Clinical Correlates of Compulsivity'.
  Cureus 2025 O'Connor S, Godfrey K, Reed S, Peill J, Rohani-Shukla C, Healy M, Robbins T, Frota Lisboa Pereira de Souza A, Tyacke R, Papasyrou M, Stenbæk D, Castro-Rodrigues P, Chiera M, Lee H, Martell J, Carhart-…
• From relaxed beliefs under psychedelics (REBUS) to revised beliefs after psychedelics (REBAS).
  Scientific reports 2025 Zeifman RJ, Spriggs MJ, Kettner H, Lyons T, Rosas FE, Mediano PAM, Erritzoe D, Carhart-Harris RL
• Study Protocol for 'PsilOCD: A Pharmacological Challenge Study Evaluating the Effects of the 5-HT2A Agonist Psilocybin on the Neurocognitive and Clinical Correlates of Compulsivity'.
  Cureus 2025 O'Connor S, Godfrey K, Reed S, Peill J, Rohani-Shukla C, Healy M, Robbins T, Frota Lisboa Pereira de Souza A, Tyacke R, Papasyrou M, Stenbæk D, Castro-Rodrigues P, Chiera M, Lee H, Martell J, Carhart-…
• LSD flattens the hierarchy of directed information flow in fast whole-brain dynamics.
  Imaging neuroscience (Cambridge, Mass.) 2025 Shinozuka K, Tewarie PKB, Luppi A, Lynn C, Roseman L, Muthukumaraswamy S, Nutt DJ, Carhart-Harris R, Deco G, Kringelbach ML
• The role of the psychedelic experience in psilocybin treatment for treatment-resistant depression.
  Journal of affective disorders 2024 Goodwin GM, Aaronson ST, Alvarez O, Carhart-Harris R, Chai-Rees J, Croal M, DeBattista C, Dunlop BW, Feifel D, Hellerstein DJ, Husain MI, Kelly JR, Kirlic N, Licht RW, Marwood L, Meyer TD, Mistry S, …
• Synergistic, multi-level understanding of psychedelics: three systematic reviews and meta-analyses of their pharmacology, neuroimaging and phenomenology.
  Translational psychiatry 2024 Shinozuka K, Jerotic K, Mediano P, Zhao AT, Preller KH, Carhart-Harris R, Kringelbach ML
• An investigation of acute physiological and psychological moderators of psychedelic-induced personality change among healthy volunteers.
  Neuroscience applied 2024 Godfrey K, Weiss B, Zhang X, Spriggs M, Peill J, Lyons T, Carhart-Harris R, Erritzoe D
• Preliminary Evidence of Sleep Improvements Following Psilocybin Administration, and their Involvement in Antidepressant Therapeutic Action.
  Current psychiatry reports 2024 Reid MJ, Kettner H, Blanken TF, Weiss B, Carhart-Harris R
• Examining differences in the effects and contexts of naturalistic psilocybin use for White participants vs. Participants of Color: A longitudinal online survey study.
  Journal of affective disorders 2024 Jones G, Lowe MX, Nayak S, Sepeda N, Kettner H, Carhart-Harris R, Jackson H, Garcia-Romeu A
• Validation of the imperial psychedelic predictor scale.
  Psychological medicine 2024 Angyus M, Osborn S, Haijen E, Erritzoe D, Peill J, Lyons T, Kettner H, Carhart-Harris R
• Reply to Letter to the Editor: "Psychedelics in Older Adults: Difficulties of a Clear Therapeutic Evidence".
  The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry 2024 Kettner H, Roseman L, Gazzaley A, Carhart-Harris RL, Pasquini L
• Effect of psilocybin versus escitalopram on depression symptom severity in patients with moderate-to-severe major depressive disorder: observational 6-month follow-up of a phase 2, double-blind, randomised, controlled trial.
  EClinicalMedicine 2024 Erritzoe D, Barba T, Greenway KT, Murphy R, Martell J, Giribaldi B, Timmermann C, Murphy-Beiner A, Jones MB, Nutt D, Weiss B, Carhart-Harris R
• Autonomic nervous system activity correlates with peak experiences induced by DMT and predicts increases in well-being.
  Journal of psychopharmacology (Oxford, England) 2024 Bonnelle V, Feilding A, Rosas FE, Nutt DJ, Carhart-Harris RL, Timmermann C
• Within-subject comparison of near-death and psychedelic experiences: acute and enduring effects.
  Neuroscience of consciousness 2024 Martial C, Carhart-Harris R, Timmermann C
• Can Psychedelic Use Benefit Meditation Practice? Examining Individual, Psychedelic, and Meditation-Related Factors.
  medRxiv : the preprint server for health sciences 2024 Jiwani Z, Goldberg SB, Stroud J, Young J, Curtin J, Dunne JD, Simonsson O, Webb CA, Carhart-Harris R, Schlosser M
• Dynamic medial parietal and hippocampal deactivations under DMT relate to sympathetic output and altered sense of time, space, and the self.
  bioRxiv : the preprint server for biology 2024 Pasquini L, Simon AJ, Gallen CL, Kettner H, Roseman L, Gazzaley A, Carhart-Harris RL, Timmermann C
• Psychotomimetic compensation versus sensitization.
  Pharmacology research & perspectives 2024 Brouwer A, Carhart-Harris RL, Raison CL
• A synergistic workspace for human consciousness revealed by Integrated Information Decomposition.
  eLife 2024 Luppi AI, Mediano PAM, Rosas FE, Allanson J, Pickard J, Carhart-Harris RL, Williams GB, Craig MM, Finoia P, Owen AM, Naci L, Menon DK, Bor D, Stamatakis EA
• Longitudinal experiences of Canadians receiving compassionate access to psilocybin-assisted psychotherapy.
  Scientific reports 2024 de la Salle S, Kettner H, Thibault Lévesque J, Garel N, Dames S, Patchett-Marble R, Rej S, Gloeckler S, Erritzoe D, Carhart-Harris R, Greenway KT
• Psilocybin desynchronizes the human brain.
  Nature 2024 Siegel JS, Subramanian S, Perry D, Kay BP, Gordon EM, Laumann TO, Reneau TR, Metcalf NV, Chacko RV, Gratton C, Horan C, Krimmel SR, Shimony JS, Schweiger JA, Wong DF, Bender DA, Scheidter KM, Whiting …
• Interrupting the Psychedelic Experience Through Contextual Manipulation to Study Experience Efficacy.
  JAMA network open 2024 Roseman L, Erritzoe D, Nutt D, Carhart-Harris R, Timmermann C
• Psychedelics in developmental stuttering to modulate brain functioning: a new therapeutic perspective?
  Frontiers in human neuroscience 2024 Pasculli G, Busan P, Jackson ES, Alm PA, De Gregorio D, Maguire GA, Goodwin GM, Gobbi G, Erritzoe D, Carhart-Harris RL
• Psychological effects of psychedelics in adolescents.
  Frontiers in child and adolescent psychiatry 2024 Izmi N, Carhart-Harris RL, Kettner H
• Study protocol for "Psilocybin in patients with fibromyalgia: brain biomarkers of action".
  Frontiers in psychiatry 2024 Bornemann J, Close JB, Ahmad K, Barba T, Godfrey K, Macdonald L, Erritzoe D, Nutt D, Carhart-Harris R
• Time-resolved coupling between connectome harmonics and subjective experience under the psychedelic DMT.
  bioRxiv : the preprint server for biology 2024 Vohryzek J, Luppi AI, Atasoy S, Deco G, Carhart-Harris RL, Timmermann C, Kringelbach ML
• Effects of Psychedelics in Older Adults: A Prospective Cohort Study.
  The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry 2024 Kettner H, Roseman L, Gazzaley A, Carhart-Harris RL, Pasquini L
• Psychedelics and the 'inner healer': Myth or mechanism?
  Journal of psychopharmacology (Oxford, England) 2024 Peill J, Marguilho M, Erritzoe D, Barba T, Greenway KT, Rosas F, Timmermann C, Carhart-Harris R
• Long-term benefits to psychological health and well-being after ceremonial use of Ayahuasca in Middle Eastern and North African immigrants and refugees.
  Frontiers in psychiatry 2024 Lowe MX, Kettner H, Jolly DRP, Carhart-Harris RL, Jackson H
• The flattening of spacetime hierarchy of the N,N-dimethyltryptamine brain state is characterized by harmonic decomposition of spacetime (HADES) framework.
  National science review 2024 Vohryzek J, Cabral J, Timmermann C, Atasoy S, Roseman L, Nutt DJ, Carhart-Harris RL, Deco G, Kringelbach ML
• Effects of discontinuation of serotonergic antidepressants prior to psilocybin therapy versus escitalopram for major depression.
  Journal of psychopharmacology (Oxford, England) 2024 Erritzoe D, Barba T, Spriggs MJ, Rosas FE, Nutt DJ, Carhart-Harris R
• Improvements in well-being following naturalistic psychedelic use and underlying mechanisms of change in older adults: A prospective cohort study.
  Research square 2024 Kettner H, Roseman L, Gazzaley A, Carhart-Harris R, Pasquini L
• Psychiatric risks for worsened mental health after psychedelic use.
  Journal of psychopharmacology (Oxford, England) 2024 Marrocu A, Kettner H, Weiss B, Zeifman RJ, Erritzoe D, Carhart-Harris RL
• The Relationship Between Changes in Mindfulness and Subsequent Changes in Well-Being Following Psychedelic Use: Prospective Cohort Study.
  JMIR formative research 2024 Jones G, Herrmann F, Bear A, Carhart-Harris R, Kettner H
• Predicting the outcome of psilocybin treatment for depression from baseline fMRI functional connectivity.
  Journal of affective disorders 2024 Copa D, Erritzoe D, Giribaldi B, Nutt D, Carhart-Harris R, Tagliazucchi E
• Brain dynamics predictive of response to psilocybin for treatment-resistant depression.
  Brain communications 2024 Vohryzek J, Cabral J, Lord LD, Fernandes HM, Roseman L, Nutt DJ, Carhart-Harris RL, Deco G, Kringelbach ML
• Effects of DMT on mental health outcomes in healthy volunteers.
  Scientific reports 2024 Timmermann C, Zeifman RJ, Erritzoe D, Nutt DJ, Carhart-Harris RL
• Psychedelics and sexual functioning: a mixed-methods study.
  Scientific reports 2024 Barba T, Kettner H, Radu C, Peill JM, Roseman L, Nutt DJ, Erritzoe D, Carhart-Harris R, Giribaldi B
• Development of the Japanese version of the Ego-Dissolution Inventory (EDI).
  Neuropsychopharmacology reports 2024 Kusudo K, Tani H, Yonezawa K, Nakajima S, Nour MM, Carhart-Harris R, Uchida H
• Interactions between classic psychedelics and serotonergic antidepressants: Effects on the acute psychedelic subjective experience, well-being and depressive symptoms from a prospective survey study.
  Journal of psychopharmacology (Oxford, England) 2024 Barbut Siva J, Barba T, Kettner H, Kuc J, Nutt DJ, Carhart-Harris R, Erritzoe D
• Assessing expectancy and suggestibility in a trial of escitalopram v. psilocybin for depression.
  Psychological medicine 2024 Szigeti B, Weiss B, Rosas FE, Erritzoe D, Nutt D, Carhart-Harris R
• Effects of External Stimulation on Psychedelic State Neurodynamics.
  ACS chemical neuroscience 2024 Mediano PAM, Rosas FE, Timmermann C, Roseman L, Nutt DJ, Feilding A, Kaelen M, Kringelbach ML, Barrett AB, Seth AK, Muthukumaraswamy S, Bor D, Carhart-Harris RL
• A role for the serotonin 2A receptor in the expansion and functioning of human transmodal cortex.
  Brain : a journal of neurology 2024 Luppi AI, Girn M, Rosas FE, Timmermann C, Roseman L, Erritzoe D, Nutt DJ, Stamatakis EA, Spreng RN, Xing L, Huttner WB, Carhart-Harris RL
• Psilocybin and Other Classic Psychedelics in Depression.
  Current topics in behavioral neurosciences 2024 Nutt DJ, Peill JM, Weiss B, Godfrey K, Carhart-Harris RL, Erritzoe D
• 5-MeO-DMT: An atypical psychedelic with unique pharmacology, phenomenology & risk?
  Psychopharmacology 2023 Dourron HM, Nichols CD, Simonsson O, Bradley M, Carhart-Harris R, Hendricks PS
• Psychological and physiological effects of extended DMT.
  Journal of psychopharmacology (Oxford, England) 2023 Luan LX, Eckernäs E, Ashton M, Rosas FE, Uthaug MV, Bartha A, Jagger S, Gascon-Perai K, Gomes L, Nutt DJ, Erritzøe D, Carhart-Harris RL, Timmermann C
• LSD-induced changes in the functional connectivity of distinct thalamic nuclei.
  NeuroImage 2023 Delli Pizzi S, Chiacchiaretta P, Sestieri C, Ferretti A, Tullo MG, Della Penna S, Martinotti G, Onofrj M, Roseman L, Timmermann C, Nutt DJ, Carhart-Harris RL, Sensi SL
• Case analysis of long-term negative psychological responses to psychedelics.
  Scientific reports 2023 Bremler R, Katati N, Shergill P, Erritzoe D, Carhart-Harris RL
• Optimized infusion rates for N,N-dimethyltryptamine to achieve a target psychedelic intensity based on a modeling and simulation framework.
  CPT: pharmacometrics & systems pharmacology 2023 Eckernäs E, Koomen J, Timmermann C, Carhart-Harris R, Röshammar D, Ashton M
• Co-use of MDMA with psilocybin/LSD may buffer against challenging experiences and enhance positive experiences.
  Scientific reports 2023 Zeifman RJ, Kettner H, Pagni BA, Mallard A, Roberts DE, Erritzoe D, Ross S, Carhart-Harris RL
• Psilocybin therapy for treatment resistant depression: prediction of clinical outcome by natural language processing.
  Psychopharmacology 2023 Dougherty RF, Clarke P, Atli M, Kuc J, Schlosser D, Dunlop BW, Hellerstein DJ, Aaronson ST, Zisook S, Young AH, Carhart-Harris R, Goodwin GM, Ryslik GA
• The difference between 'placebo group' and 'placebo control': a case study in psychedelic microdosing.
  Scientific reports 2023 Szigeti B, Nutt D, Carhart-Harris R, Erritzoe D
• Assessing the risk of symptom worsening in psilocybin-assisted therapy for depression: A systematic review and individual participant data meta-analysis.
  Psychiatry research 2023 Simonsson O, Carlbring P, Carhart-Harris R, Davis AK, Nutt DJ, Griffiths RR, Erritzoe D, Goldberg SB
• Personality Change in a Trial of Psilocybin Therapy vs Escitalopram Treatment for Depression - CORRIGENDUM.
  Psychological medicine 2023 Weiss B, Ginige I, Shannon L, Giribaldi B, Murphy-Beiner A, Murphy R, Baker-Jones M, Martell J, Nutt DJ, Carhart-Harris RL, Erritzoe D
• Pattern breaking: a complex systems approach to psychedelic medicine.
  Neuroscience of consciousness 2023 Hipólito I, Mago J, Rosas FE, Carhart-Harris R
• In vivo mapping of pharmacologically induced functional reorganization onto the human brain's neurotransmitter landscape.
  Science advances 2023 Luppi AI, Hansen JY, Adapa R, Carhart-Harris RL, Roseman L, Timmermann C, Golkowski D, Ranft A, Ilg R, Jordan D, Bonhomme V, Vanhaudenhuyse A, Demertzi A, Jaquet O, Bahri MA, Alnagger NLN, Cardone P, …
• Personality change in a trial of psilocybin therapy v. escitalopram treatment for depression.
  Psychological medicine 2023 Weiss B, Ginige I, Shannon L, Giribaldi B, Murphy-Beiner A, Murphy R, Baker-Jones M, Martell J, Nutt DJ, Carhart-Harris RL, Erritzoe D
• Emerging Challenges for Psychedelic Therapy.
  JAMA psychiatry 2023 Aday JS, Carhart-Harris RL, Woolley JD
• Time-resolved network control analysis links reduced control energy under DMT with the serotonin 2a receptor, signal diversity, and subjective experience.
  bioRxiv : the preprint server for biology 2023 Singleton SP, Timmermann C, Luppi AI, Eckernäs E, Roseman L, Carhart-Harris RL, Kuceyeski A
• How does psilocybin therapy work? An exploration of experiential avoidance as a putative mechanism of change.
  Journal of affective disorders 2023 Zeifman RJ, Wagner AC, Monson CM, Carhart-Harris RL
• A critical evaluation of QIDS-SR-16 using data from a trial of psilocybin therapy versus escitalopram treatment for depression.
  Journal of psychopharmacology (Oxford, England) 2023 Weiss B, Erritzoe D, Giribaldi B, Nutt DJ, Carhart-Harris RL
• Increased low-frequency brain responses to music after psilocybin therapy for depression.
  Journal of affective disorders 2023 Wall MB, Lam C, Ertl N, Kaelen M, Roseman L, Nutt DJ, Carhart-Harris RL
• A whole-brain model of the neural entropy increase elicited by psychedelic drugs.
  Scientific reports 2023 Herzog R, Mediano PAM, Rosas FE, Lodder P, Carhart-Harris R, Perl YS, Tagliazucchi E, Cofre R
• Spatial Correspondence of LSD-Induced Variations on Brain Functioning at Rest With Serotonin Receptor Expression.
  Biological psychiatry. Cognitive neuroscience and neuroimaging 2023 Delli Pizzi S, Chiacchiaretta P, Sestieri C, Ferretti A, Onofrj M, Della Penna S, Roseman L, Timmermann C, Nutt DJ, Carhart-Harris RL, Sensi SL
• Editorial: Frontiers in psychodynamic neuroscience.
  Frontiers in human neuroscience 2023 Cieri F, Carhart-Harris RL, Mathys C, Turnbull O, Solms M
• Human brain effects of DMT assessed via EEG-fMRI.
  Proceedings of the National Academy of Sciences of the United States of America 2023 Timmermann C, Roseman L, Haridas S, Rosas FE, Luan L, Kettner H, Martell J, Erritzoe D, Tagliazucchi E, Pallavicini C, Girn M, Alamia A, Leech R, Nutt DJ, Carhart-Harris RL
• N,N-dimethyltryptamine affects electroencephalography response in a concentration-dependent manner-A pharmacokinetic/pharmacodynamic analysis.
  CPT: pharmacometrics & systems pharmacology 2023 Eckernäs E, Timmermann C, Carhart-Harris R, Röshammar D, Ashton M
• A complex systems perspective on psychedelic brain action.
  Trends in cognitive sciences 2023 Girn M, Rosas FE, Daws RE, Gallen CL, Gazzaley A, Carhart-Harris RL
• LSD-induced increase of Ising temperature and algorithmic complexity of brain dynamics.
  PLoS computational biology 2023 Ruffini G, Damiani G, Lozano-Soldevilla D, Deco N, Rosas FE, Kiani NA, Ponce-Alvarez A, Kringelbach ML, Carhart-Harris R, Deco G
• Translational Challenges in Psychedelic Medicine.
  The New England journal of medicine 2023 Carhart-Harris RL
• Distributed harmonic patterns of structure-function dependence orchestrate human consciousness.
  Communications biology 2023 Luppi AI, Vohryzek J, Kringelbach ML, Mediano PAM, Craig MM, Adapa R, Carhart-Harris RL, Roseman L, Pappas I, Peattie ARD, Manktelow AE, Sahakian BJ, Finoia P, Williams GB, Allanson J, Pickard JD, …
• Among psychedelic-experienced users, only past use of psilocybin reliably predicts nature relatedness.
  Journal of psychopharmacology (Oxford, England) 2023 Forstmann M, Kettner HS, Sagioglou C, Irvine A, Gandy S, Carhart-Harris RL, Luke D
• Canalization and plasticity in psychopathology.
  Neuropharmacology 2022 Carhart-Harris RL, Chandaria S, Erritzoe DE, Gazzaley A, Girn M, Kettner H, Mediano PAM, Nutt DJ, Rosas FE, Roseman L, Timmermann C, Weiss B, Zeifman RJ, Friston KJ
• Oxygen and the Spark of Human Brain Evolution: Complex Interactions of Metabolism and Cortical Expansion across Development and Evolution.
  The Neuroscientist : a review journal bringing neurobiology, neurology and psychiatry 2022 Luppi AI, Rosas FE, Noonan MP, Mediano PAM, Kringelbach ML, Carhart-Harris RL, Stamatakis EA, Vernon AC, Turkheimer FE
• Changes in music-evoked emotion and ventral striatal functional connectivity after psilocybin therapy for depression.
  Journal of psychopharmacology (Oxford, England) 2022 Shukuroglou M, Roseman L, Wall M, Nutt D, Kaelen M, Carhart-Harris R
• Effect of lysergic acid diethylamide (LSD) on reinforcement learning in humans.
  Psychological medicine 2022 Kanen JW, Luo Q, Rostami Kandroodi M, Cardinal RN, Robbins TW, Nutt DJ, Carhart-Harris RL, den Ouden HEM
• Body mass index (BMI) does not predict responses to psilocybin.
  Journal of psychopharmacology (Oxford, England) 2022 Spriggs MJ, Giribaldi B, Lyons T, Rosas FE, Kärtner LS, Buchborn T, Douglass HM, Roseman L, Timmermann C, Erritzoe D, Nutt DJ, Carhart-Harris RL
• Single-Dose Psilocybin for a Treatment-Resistant Episode of Major Depression.
  The New England journal of medicine 2022 Goodwin GM, Aaronson ST, Alvarez O, Arden PC, Baker A, Bennett JC, Bird C, Blom RE, Brennan C, Brusch D, Burke L, Campbell-Coker K, Carhart-Harris R, Cattell J, Daniel A, DeBattista C, Dunlop BW, …
• A Bayesian Reanalysis of a Trial of Psilocybin versus Escitalopram for Depression.
  Psychedelic medicine (New Rochelle, N.Y.) 2022 Nayak SM, Bari BA, Yaden DB, Spriggs MJ, Rosas FE, Peill JM, Giribaldi B, Erritzoe D, Nutt DJ, Carhart-Harris R
• Receptor-informed network control theory links LSD and psilocybin to a flattening of the brain's control energy landscape.
  Nature communications 2022 Singleton SP, Luppi AI, Carhart-Harris RL, Cruzat J, Roseman L, Nutt DJ, Deco G, Kringelbach ML, Stamatakis EA, Kuceyeski A
• Effects of classic psychedelic drugs on turbulent signatures in brain dynamics.
  Network neuroscience (Cambridge, Mass.) 2022 Cruzat J, Perl YS, Escrichs A, Vohryzek J, Timmermann C, Roseman L, Luppi AI, Ibañez A, Nutt D, Carhart-Harris R, Tagliazucchi E, Deco G, Kringelbach ML
• Population pharmacokinetic/pharmacodynamic modeling of the psychedelic experience induced by N,N-dimethyltryptamine - Implications for dose considerations.
  Clinical and translational science 2022 Eckernäs E, Timmermann C, Carhart-Harris R, Röshammar D, Ashton M
• Retraction Note: A mechanistic model of the neural entropy increase elicited by psychedelic drugs.
  Scientific reports 2022 Herzog R, Mediano PAM, Rosas FE, Carhart-Harris R, Perl YS, Tagliazucchi E, Cofre R
• Psychedelics and schizophrenia: Distinct alterations to Bayesian inference.
  NeuroImage 2022 Rajpal H, Mediano PAM, Rosas FE, Timmermann CB, Brugger S, Muthukumaraswamy S, Seth AK, Bor D, Carhart-Harris RL, Jensen HJ
• Effects of psilocybin versus escitalopram on rumination and thought suppression in depression.
  BJPsych open 2022 Barba T, Buehler S, Kettner H, Radu C, Cunha BG, Nutt DJ, Erritzoe D, Roseman L, Carhart-Harris R
• The Watts Connectedness Scale: a new scale for measuring a sense of connectedness to self, others, and world.
  Psychopharmacology 2022 Watts R, Kettner H, Geerts D, Gandy S, Kartner L, Mertens L, Timmermann C, Nour MM, Kaelen M, Nutt D, Carhart-Harris R, Roseman L
• Antidepressant effects of a psychedelic experience in a large prospective naturalistic sample.
  Journal of psychopharmacology (Oxford, England) 2022 Nygart VA, Pommerencke LM, Haijen E, Kettner H, Kaelen M, Mortensen EL, Nutt DJ, Carhart-Harris RL, Erritzoe D
• Phenomenology and content of the inhaled N, N-dimethyltryptamine (N, N-DMT) experience.
  Scientific reports 2022 Lawrence DW, Carhart-Harris R, Griffiths R, Timmermann C
• Greater than the parts: a review of the information decomposition approach to causal emergence.
  Philosophical transactions. Series A, Mathematical, physical, and engineering sciences 2022 Mediano PAM, Rosas FE, Luppi AI, Jensen HJ, Seth AK, Barrett AB, Carhart-Harris RL, Bor D
• Psychedelic resting-state neuroimaging: A review and perspective on balancing replication and novel analyses.
  Neuroscience and biobehavioral reviews 2022 McCulloch DE, Knudsen GM, Barrett FS, Doss MK, Carhart-Harris RL, Rosas FE, Deco G, Kringelbach ML, Preller KH, Ramaekers JG, Mason NL, Müller F, Fisher PM
• Serotonergic psychedelic drugs LSD and psilocybin reduce the hierarchical differentiation of unimodal and transmodal cortex.
  NeuroImage 2022 Girn M, Roseman L, Bernhardt B, Smallwood J, Carhart-Harris R, Nathan Spreng R
• Increased global integration in the brain after psilocybin therapy for depression.
  Nature medicine 2022 Daws RE, Timmermann C, Giribaldi B, Sexton JD, Wall MB, Erritzoe D, Roseman L, Nutt D, Carhart-Harris R
• Therapeutic Alliance and Rapport Modulate Responses to Psilocybin Assisted Therapy for Depression.
  Frontiers in pharmacology 2022 Murphy R, Kettner H, Zeifman R, Giribaldi B, Kartner L, Martell J, Read T, Murphy-Beiner A, Baker-Jones M, Nutt D, Erritzoe D, Watts R, Carhart-Harris R
• Consciousness is supported by near-critical slow cortical electrodynamics.
  Proceedings of the National Academy of Sciences of the United States of America 2022 Toker D, Pappas I, Lendner JD, Frohlich J, Mateos DM, Muthukumaraswamy S, Carhart-Harris R, Paff M, Vespa PM, Monti MM, Sommer FT, Knight RT, D'Esposito M
• Development and application of a highly sensitive LC-MS/MS method for simultaneous quantification of N,N-dimethyltryptamine and two of its metabolites in human plasma.
  Journal of pharmaceutical and biomedical analysis 2022 Eckernäs E, Bendrioua A, Cancellerini C, Timmermann C, Carhart-Harris R, Hoffmann KJ, Ashton M
• Validation of the Psychological Insight Scale: A new scale to assess psychological insight following a psychedelic experience.
  Journal of psychopharmacology (Oxford, England) 2022 Peill JM, Trinci KE, Kettner H, Mertens LJ, Roseman L, Timmermann C, Rosas FE, Lyons T, Carhart-Harris RL
• Examining Psychedelic-Induced Changes in Social Functioning and Connectedness in a Naturalistic Online Sample Using the Five-Factor Model of Personality.
  Frontiers in psychology 2021 Weiss B, Nygart V, Pommerencke LM, Carhart-Harris RL, Erritzoe D
• Psychedelics alter metaphysical beliefs.
  Scientific reports 2021 Timmermann C, Kettner H, Letheby C, Roseman L, Rosas FE, Carhart-Harris RL
• What it is like to be a bit: an integrated information decomposition account of emergent mental phenomena.
  Neuroscience of consciousness 2021 Luppi AI, Mediano PAM, Rosas FE, Harrison DJ, Carhart-Harris RL, Bor D, Stamatakis EA
• Self-Medication for Chronic Pain Using Classic Psychedelics: A Qualitative Investigation to Inform Future Research.
  Frontiers in psychiatry 2021 Bornemann J, Close JB, Spriggs MJ, Carhart-Harris R, Roseman L
• Psychedelic experience dose-dependently modulated by cannabis: results of a prospective online survey.
  Psychopharmacology 2021 Kuc J, Kettner H, Rosas F, Erritzoe D, Haijen E, Kaelen M, Nutt D, Carhart-Harris RL
• Study Protocol for "Psilocybin as a Treatment for Anorexia Nervosa: A Pilot Study".
  Frontiers in psychiatry 2021 Spriggs MJ, Douglass HM, Park RJ, Read T, Danby JL, de Magalhães FJC, Alderton KL, Williams TM, Blemings A, Lafrance A, Nicholls DE, Erritzoe D, Nutt DJ, Carhart-Harris RL
• Co-design of Guidance for Patient and Public Involvement in Psychedelic Research.
  Frontiers in psychiatry 2021 Close JB, Bornemann J, Piggin M, Jayacodi S, Luan LX, Carhart-Harris R, Spriggs MJ
• Prefrontal contributions to the stability and variability of thought and conscious experience.
  Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 2021 Zamani A, Carhart-Harris R, Christoff K
• Psilocybin for Depression. Reply.
  The New England journal of medicine 2021 Carhart-Harris R, Blemings A, Nutt DJ
• Turn on, Tune in, and Drop out: Predictors of Attrition in a Prospective Observational Cohort Study on Psychedelic Use.
  Journal of medical Internet research 2021 Hübner S, Haijen E, Kaelen M, Carhart-Harris RL, Kettner H
• Does Psychedelic Therapy Have a Transdiagnostic Action and Prophylactic Potential?
  Frontiers in psychiatry 2021 Kocárová R, Horácek J, Carhart-Harris R
• Losing the Self in Near-Death Experiences: The Experience of Ego-Dissolution.
  Brain sciences 2021 Martial C, Fontaine G, Gosseries O, Carhart-Harris R, Timmermann C, Laureys S, Cassol H
• Associations between lifetime classic psychedelic use and cardiometabolic diseases.
  Scientific reports 2021 Simonsson O, Osika W, Carhart-Harris R, Hendricks PS
• Sustained, Multifaceted Improvements in Mental Well-Being Following Psychedelic Experiences in a Prospective Opportunity Sample.
  Frontiers in psychiatry 2021 Mans K, Kettner H, Erritzoe D, Haijen ECHM, Kaelen M, Carhart-Harris RL
• Psychedelics and health behaviour change.
  Journal of psychopharmacology (Oxford, England) 2021 Teixeira PJ, Johnson MW, Timmermann C, Watts R, Erritzoe D, Douglass H, Kettner H, Carhart-Harris RL
• Relational Processes in Ayahuasca Groups of Palestinians and Israelis.
  Frontiers in pharmacology 2021 Roseman L, Ron Y, Saca A, Ginsberg N, Luan L, Karkabi N, Doblin R, Carhart-Harris R
• Can pragmatic research, real-world data and digital technologies aid the development of psychedelic medicine?
  Journal of psychopharmacology (Oxford, England) 2021 Carhart-Harris RL, Wagner AC, Agrawal M, Kettner H, Rosenbaum JF, Gazzaley A, Nutt DJ, Erritzoe D
• Trial of Psilocybin versus Escitalopram for Depression.
  The New England journal of medicine 2021 Carhart-Harris R, Giribaldi B, Watts R, Baker-Jones M, Murphy-Beiner A, Murphy R, Martell J, Blemings A, Erritzoe D, Nutt DJ
• Psychedelic Communitas: Intersubjective Experience During Psychedelic Group Sessions Predicts Enduring Changes in Psychological Wellbeing and Social Connectedness.
  Frontiers in pharmacology 2021 Kettner H, Rosas FE, Timmermann C, Kärtner L, Carhart-Harris RL, Roseman L
• Association Between Lifetime Classic Psychedelic Use and Hypertension in the Past Year.
  Hypertension (Dallas, Tex. : 1979) 2021 Simonsson O, Hendricks PS, Carhart-Harris R, Kettner H, Osika W
• Self-blinding citizen science to explore psychedelic microdosing.
  eLife 2021 Szigeti B, Kartner L, Blemings A, Rosas F, Feilding A, Nutt DJ, Carhart-Harris RL, Erritzoe D
• Neural and subjective effects of inhaled N,N-dimethyltryptamine in natural settings.
  Journal of psychopharmacology (Oxford, England) 2021 Pallavicini C, Cavanna F, Zamberlan F, de la Fuente LA, Ilksoy Y, Perl YS, Arias M, Romero C, Carhart-Harris R, Timmermann C, Tagliazucchi E
• Trends in the Top-Cited Articles on Classic Psychedelics.
  Journal of psychoactive drugs 2021 Lawrence DW, Sharma B, Griffiths RR, Carhart-Harris R
• The Current Status of Psychedelics in Psychiatry.
  JAMA psychiatry 2021 Nutt D, Carhart-Harris R
• Increased sensitivity to strong perturbations in a whole-brain model of LSD.
  NeuroImage 2021 Jobst BM, Atasoy S, Ponce-Alvarez A, Sanjuán A, Roseman L, Kaelen M, Carhart-Harris R, Kringelbach ML, Deco G
• Positive expectations predict improved mental-health outcomes linked to psychedelic microdosing.
  Scientific reports 2021 Kaertner LS, Steinborn MB, Kettner H, Spriggs MJ, Roseman L, Buchborn T, Balaet M, Timmermann C, Erritzoe D, Carhart-Harris RL
• Reconciling emergences: An information-theoretic approach to identify causal emergence in multivariate data.
  PLoS computational biology 2020 Rosas FE, Mediano PAM, Jensen HJ, Seth AK, Barrett AB, Carhart-Harris RL, Bor D
• LSD alters dynamic integration and segregation in the human brain.
  NeuroImage 2020 Luppi AI, Carhart-Harris RL, Roseman L, Pappas I, Menon DK, Stamatakis EA
• The entropic tongue: Disorganization of natural language under LSD.
  Consciousness and cognition 2020 Sanz C, Pallavicini C, Carrillo F, Zamberlan F, Sigman M, Mota N, Copelli M, Ribeiro S, Nutt D, Carhart-Harris R, Tagliazucchi E
• The potential synergistic effects between psychedelic administration and nature contact for the improvement of mental health.
  Health psychology open 2020 Gandy S, Forstmann M, Carhart-Harris RL, Timmermann C, Luke D, Watts R
• Hallucinations Under Psychedelics and in the Schizophrenia Spectrum: An Interdisciplinary and Multiscale Comparison.
  Schizophrenia bulletin 2020 Leptourgos P, Fortier-Davy M, Carhart-Harris R, Corlett PR, Dupuis D, Halberstadt AL, Kometer M, Kozakova E, LarØi F, Noorani TN, Preller KH, Waters F, Zaytseva Y, Jardri R
• Therapeutic effects of classic serotonergic psychedelics: A systematic review of modern-era clinical studies.
  Acta psychiatrica Scandinavica 2020 Andersen KAA, Carhart-Harris R, Nutt DJ, Erritzoe D
• Pivotal mental states.
  Journal of psychopharmacology (Oxford, England) 2020 Brouwer A, Carhart-Harris RL
• Correction: DMT alters cortical travelling waves.
  eLife 2020 Alamia A, Timmermann C, Nutt DJ, VanRullen R, Carhart-Harris RL
• A mechanistic model of the neural entropy increase elicited by psychedelic drugs.
  Scientific reports 2020 Herzog R, Mediano PAM, Rosas FE, Carhart-Harris R, Perl YS, Tagliazucchi E, Cofre R
• DMT alters cortical travelling waves.
  eLife 2020 Alamia A, Timmermann C, Nutt DJ, VanRullen R, Carhart-Harris RL
• Positive effects of psychedelics on depression and wellbeing scores in individuals reporting an eating disorder.
  Eating and weight disorders : EWD 2020 Spriggs MJ, Kettner H, Carhart-Harris RL
• Post-Psychedelic Reductions in Experiential Avoidance Are Associated With Decreases in Depression Severity and Suicidal Ideation.
  Frontiers in psychiatry 2020 Zeifman RJ, Wagner AC, Watts R, Kettner H, Mertens LJ, Carhart-Harris RL
• Serotonergic psychedelics LSD & psilocybin increase the fractal dimension of cortical brain activity in spatial and temporal domains.
  NeuroImage 2020 Varley TF, Carhart-Harris R, Roseman L, Menon DK, Stamatakis EA
• Acute effects of MDMA on trust, cooperative behaviour and empathy: A double-blind, placebo-controlled experiment.
  Journal of psychopharmacology (Oxford, England) 2020 Borissova A, Ferguson B, Wall MB, Morgan CJ, Carhart-Harris RL, Bolstridge M, Bloomfield MA, Williams TM, Feilding A, Murphy K, Tyacke RJ, Erritzoe D, Stewart L, Wolff K, Nutt D, Curran HV, Lawn W
• Dynamic coupling of whole-brain neuronal and neurotransmitter systems.
  Proceedings of the National Academy of Sciences of the United States of America 2020 Kringelbach ML, Cruzat J, Cabral J, Knudsen GM, Carhart-Harris R, Whybrow PC, Logothetis NK, Deco G
• Psychedelic Psychiatry's Brave New World.
  Cell 2020 Nutt D, Erritzoe D, Carhart-Harris R
• Updating the dynamic framework of thought: Creativity and psychedelics.
  NeuroImage 2020 Girn M, Mills C, Roseman L, Carhart-Harris RL, Christoff K
• Therapeutic mechanisms of psilocybin: Changes in amygdala and prefrontal functional connectivity during emotional processing after psilocybin for treatment-resistant depression.
  Journal of psychopharmacology (Oxford, England) 2020 Mertens LJ, Wall MB, Roseman L, Demetriou L, Nutt DJ, Carhart-Harris RL
• Safety, tolerability, pharmacokinetics, and pharmacodynamics of low dose lysergic acid diethylamide (LSD) in healthy older volunteers.
  Psychopharmacology 2019 Family N, Maillet EL, Williams LTJ, Krediet E, Carhart-Harris RL, Williams TM, Nichols CD, Goble DJ, Raz S
• Decreased directed functional connectivity in the psychedelic state.
  NeuroImage 2019 Barnett L, Muthukumaraswamy SD, Carhart-Harris RL, Seth AK
• From Egoism to Ecoism: Psychedelics Increase Nature Relatedness in a State-Mediated and Context-Dependent Manner.
  International journal of environmental research and public health 2019 Kettner H, Gandy S, Haijen ECHM, Carhart-Harris RL
• Neural correlates of the DMT experience assessed with multivariate EEG.
  Scientific reports 2019 Timmermann C, Roseman L, Schartner M, Milliere R, Williams LTJ, Erritzoe D, Muthukumaraswamy S, Ashton M, Bendrioua A, Kaur O, Turton S, Nour MM, Day CM, Leech R, Nutt DJ, Carhart-Harris RL
• Emotional breakthrough and psychedelics: Validation of the Emotional Breakthrough Inventory.
  Journal of psychopharmacology (Oxford, England) 2019 Roseman L, Haijen E, Idialu-Ikato K, Kaelen M, Watts R, Carhart-Harris R
• REBUS and the Anarchic Brain: Toward a Unified Model of the Brain Action of Psychedelics.
  Pharmacological reviews 2019 Carhart-Harris RL, Friston KJ
• Spectral signatures of serotonergic psychedelics and glutamatergic dissociatives.
  NeuroImage 2019 Pallavicini C, Vilas MG, Villarreal M, Zamberlan F, Muthukumaraswamy S, Nutt D, Carhart-Harris R, Tagliazucchi E
• Replication and extension of a model predicting response to psilocybin.
  Psychopharmacology 2019 Russ SL, Carhart-Harris RL, Maruyama G, Elliott MS
• Dynamical exploration of the repertoire of brain networks at rest is modulated by psilocybin.
  NeuroImage 2019 Lord LD, Expert P, Atasoy S, Roseman L, Rapuano K, Lambiotte R, Nutt DJ, Deco G, Carhart-Harris RL, Kringelbach ML, Cabral J
• Psychedelics as a treatment for disorders of consciousness.
  Neuroscience of consciousness 2019 Scott G, Carhart-Harris RL
• Recreational use of psychedelics is associated with elevated personality trait openness: Exploration of associations with brain serotonin markers.
  Journal of psychopharmacology (Oxford, England) 2019 Erritzoe D, Smith J, Fisher PM, Carhart-Harris R, Frokjaer VG, Knudsen GM
• How do psychedelics work?
  Current opinion in psychiatry 2019 Carhart-Harris RL
• Predicting Responses to Psychedelics: A Prospective Study.
  Frontiers in pharmacology 2018 Haijen ECHM, Kaelen M, Roseman L, Timmermann C, Kettner H, Russ S, Nutt D, Daws RE, Hampshire ADG, Lorenz R, Carhart-Harris RL
• Common neural signatures of psychedelics: Frequency-specific energy changes and repertoire expansion revealed using connectome-harmonic decomposition.
  Progress in brain research 2018 Atasoy S, Vohryzek J, Deco G, Carhart-Harris RL, Kringelbach ML
• More Realistic Forecasting of Future Life Events After Psilocybin for Treatment-Resistant Depression.
  Frontiers in psychology 2018 Lyons T, Carhart-Harris RL
• Serotonin, psychedelics and psychiatry.
  World psychiatry : official journal of the World Psychiatric Association (WPA) 2018 Carhart-Harris RL
• Whole-Brain Multimodal Neuroimaging Model Using Serotonin Receptor Maps Explains Non-linear Functional Effects of LSD.
  Current biology : CB 2018 Deco G, Cruzat J, Cabral J, Knudsen GM, Carhart-Harris RL, Whybrow PC, Logothetis NK, Kringelbach ML
• Psychedelics, Meditation, and Self-Consciousness.
  Frontiers in psychology 2018 Millière R, Carhart-Harris RL, Roseman L, Trautwein FM, Berkovich-Ohana A
• DMT Models the Near-Death Experience.
  Frontiers in psychology 2018 Timmermann C, Roseman L, Williams L, Erritzoe D, Martial C, Cassol H, Laureys S, Nutt D, Carhart-Harris R
• Effects of psilocybin therapy on personality structure.
  Acta psychiatrica Scandinavica 2018 Erritzoe D, Roseman L, Nour MM, MacLean K, Kaelen M, Nutt DJ, Carhart-Harris RL
• Psilocybin and MDMA reduce costly punishment in the Ultimatum Game.
  Scientific reports 2018 Gabay AS, Carhart-Harris RL, Mazibuko N, Kempton MJ, Morrison PD, Nutt DJ, Mehta MA
• Correction to: The hidden therapist: evidence for a central role of music in psychedelic therapy.
  Psychopharmacology 2018 Kaelen M, Giribaldi B, Raine J, Evans L, Timmermann C, Rodriguez N, Roseman L, Feilding A, Nutt D, Carhart-Harris R
• Natural speech algorithm applied to baseline interview data can predict which patients will respond to psilocybin for treatment-resistant depression.
  Journal of affective disorders 2018 Carrillo F, Sigman M, Fernández Slezak D, Ashton P, Fitzgerald L, Stroud J, Nutt DJ, Carhart-Harris RL
• The entropic brain - revisited.
  Neuropharmacology 2018 Carhart-Harris RL
• Psychedelics and the essential importance of context.
  Journal of psychopharmacology (Oxford, England) 2018 Carhart-Harris RL, Roseman L, Haijen E, Erritzoe D, Watts R, Branchi I, Kaelen M
• The hidden therapist: evidence for a central role of music in psychedelic therapy.
  Psychopharmacology 2018 Kaelen M, Giribaldi B, Raine J, Evans L, Timmerman C, Rodriguez N, Roseman L, Feilding A, Nutt D, Carhart-Harris R
• Increased nature relatedness and decreased authoritarian political views after psilocybin for treatment-resistant depression.
  Journal of psychopharmacology (Oxford, England) 2018 Lyons T, Carhart-Harris RL
• Quality of Acute Psychedelic Experience Predicts Therapeutic Efficacy of Psilocybin for Treatment-Resistant Depression.
  Frontiers in pharmacology 2018 Roseman L, Nutt DJ, Carhart-Harris RL
• Increased amygdala responses to emotional faces after psilocybin for treatment-resistant depression.
  Neuropharmacology 2017 Roseman L, Demetriou L, Wall MB, Nutt DJ, Carhart-Harris RL
• Connectome-harmonic decomposition of human brain activity reveals dynamical repertoire re-organization under LSD.
  Scientific reports 2017 Atasoy S, Roseman L, Kaelen M, Kringelbach ML, Deco G, Carhart-Harris RL
• LSD modulates effective connectivity and neural adaptation mechanisms in an auditory oddball paradigm.
  Neuropharmacology 2017 Timmermann C, Spriggs MJ, Kaelen M, Leech R, Nutt DJ, Moran RJ, Carhart-Harris RL, Muthukumaraswamy SD
• Psilocybin with psychological support for treatment-resistant depression: six-month follow-up.
  Psychopharmacology 2017 Carhart-Harris RL, Bolstridge M, Day CMJ, Rucker J, Watts R, Erritzoe DE, Kaelen M, Giribaldi B, Bloomfield M, Pilling S, Rickard JA, Forbes B, Feilding A, Taylor D, Curran HV, Nutt DJ
• Psilocybin with psychological support improves emotional face recognition in treatment-resistant depression.
  Psychopharmacology 2017 Stroud JB, Freeman TP, Leech R, Hindocha C, Lawn W, Nutt DJ, Curran HV, Carhart-Harris RL
• Psilocybin for treatment-resistant depression: fMRI-measured brain mechanisms.
  Scientific reports 2017 Carhart-Harris RL, Roseman L, Bolstridge M, Demetriou L, Pannekoek JN, Wall MB, Tanner M, Kaelen M, McGonigle J, Murphy K, Leech R, Curran HV, Nutt DJ
• Serotonin and brain function: a tale of two receptors.
  Journal of psychopharmacology (Oxford, England) 2017 Carhart-Harris RL, Nutt DJ
• Psychedelics and connectedness.
  Psychopharmacology 2017 Carhart-Harris RL, Erritzoe D, Haijen E, Kaelen M, Watts R
• Psychedelics, Personality and Political Perspectives.
  Journal of psychoactive drugs 2017 Nour MM, Evans L, Carhart-Harris RL
• The Therapeutic Potential of Psychedelic Drugs: Past, Present, and Future.
  Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 2017 Carhart-Harris RL, Goodwin GM
• Increased spontaneous MEG signal diversity for psychoactive doses of ketamine, LSD and psilocybin.
  Scientific reports 2017 Schartner MM, Carhart-Harris RL, Barrett AB, Seth AK, Muthukumaraswamy SD
• Psychedelics and the science of self-experience.
  The British journal of psychiatry : the journal of mental science 2017 Nour MM, Carhart-Harris RL
• Concerns regarding conclusions made about LSD-treatments (received 25 October 2016).
  History of psychiatry 2017 Erritzoe D, Nutt DJ, Carhart-Harris R
• Altered Insula Connectivity under MDMA.
  Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 2017 Walpola IC, Nest T, Roseman L, Erritzoe D, Feilding A, Nutt DJ, Carhart-Harris RL
• Question-based Drug Development for psilocybin - Authors' reply.
  The lancet. Psychiatry 2016 Carhart-Harris RL, Nutt DJ
• Ego-Dissolution and Psychedelics: Validation of the Ego-Dissolution Inventory (EDI).
  Frontiers in human neuroscience 2016 Nour MM, Evans L, Nutt D, Carhart-Harris RL
• Psilocybin with psychological support for treatment-resistant depression: an open-label feasibility study.
  The lancet. Psychiatry 2016 Carhart-Harris RL, Bolstridge M, Rucker J, Day CM, Erritzoe D, Kaelen M, Bloomfield M, Rickard JA, Forbes B, Feilding A, Taylor D, Pilling S, Curran VH, Nutt DJ
• LSD-induced entropic brain activity predicts subsequent personality change.
  Human brain mapping 2016 Lebedev AV, Kaelen M, Lövdén M, Nilsson J, Feilding A, Nutt DJ, Carhart-Harris RL
• LSD alters eyes-closed functional connectivity within the early visual cortex in a retinotopic fashion.
  Human brain mapping 2016 Roseman L, Sereno MI, Leech R, Kaelen M, Orban C, McGonigle J, Feilding A, Nutt DJ, Carhart-Harris RL
• Increased Global Functional Connectivity Correlates with LSD-Induced Ego Dissolution.
  Current biology : CB 2016 Tagliazucchi E, Roseman L, Kaelen M, Orban C, Muthukumaraswamy SD, Murphy K, Laufs H, Leech R, McGonigle J, Crossley N, Bullmore E, Williams T, Bolstridge M, Feilding A, Nutt DJ, Carhart-Harris R
• LSD modulates music-induced imagery via changes in parahippocampal connectivity.
  European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 2016 Kaelen M, Roseman L, Kahan J, Santos-Ribeiro A, Orban C, Lorenz R, Barrett FS, Bolstridge M, Williams T, Williams L, Wall MB, Feilding A, Muthukumaraswamy S, Nutt DJ, Carhart-Harris R
• Neural correlates of the LSD experience revealed by multimodal neuroimaging.
  Proceedings of the National Academy of Sciences of the United States of America 2016 Carhart-Harris RL, Muthukumaraswamy S, Roseman L, Kaelen M, Droog W, Murphy K, Tagliazucchi E, Schenberg EE, Nest T, Orban C, Leech R, Williams LT, Williams TM, Bolstridge M, Sessa B, McGonigle J, …
• A placebo-controlled investigation of synaesthesia-like experiences under LSD.
  Neuropsychologia 2016 Terhune DB, Luke DP, Kaelen M, Bolstridge M, Feilding A, Nutt D, Carhart-Harris R, Ward J
• Decreased mental time travel to the past correlates with default-mode network disintegration under lysergic acid diethylamide.
  Journal of psychopharmacology (Oxford, England) 2016 Speth J, Speth C, Kaelen M, Schloerscheidt AM, Feilding A, Nutt DJ, Carhart-Harris RL
• The paradoxical psychological effects of lysergic acid diethylamide (LSD).
  Psychological medicine 2016 Carhart-Harris RL, Kaelen M, Bolstridge M, Williams TM, Williams LT, Underwood R, Feilding A, Nutt DJ
• LSD enhances the emotional response to music.
  Psychopharmacology 2015 Kaelen M, Barrett FS, Roseman L, Lorenz R, Family N, Bolstridge M, Curran HV, Feilding A, Nutt DJ, Carhart-Harris RL
• Finding the self by losing the self: Neural correlates of ego-dissolution under psilocybin.
  Human brain mapping 2015 Lebedev AV, Lövdén M, Rosenthal G, Feilding A, Nutt DJ, Carhart-Harris RL
• Drug models of schizophrenia.
  Therapeutic advances in psychopharmacology 2015 Steeds H, Carhart-Harris RL, Stone JM
• Homological scaffolds of brain functional networks.
  Journal of the Royal Society, Interface 2014 Petri G, Expert P, Turkheimer F, Carhart-Harris R, Nutt D, Hellyer PJ, Vaccarino F
• LSD enhances suggestibility in healthy volunteers.
  Psychopharmacology 2014 Carhart-Harris RL, Kaelen M, Whalley MG, Bolstridge M, Feilding A, Nutt DJ
• Enhanced repertoire of brain dynamical states during the psychedelic experience.
  Human brain mapping 2014 Tagliazucchi E, Carhart-Harris R, Leech R, Nutt D, Chialvo DR
• Spatial dependencies between large-scale brain networks.
  PloS one 2014 Leech R, Scott G, Carhart-Harris R, Turkheimer F, Taylor-Robinson SD, Sharp DJ
• The effects of psilocybin and MDMA on between-network resting state functional connectivity in healthy volunteers.
  Frontiers in human neuroscience 2014 Roseman L, Leech R, Feilding A, Nutt DJ, Carhart-Harris RL
• Was it a vision or a waking dream?
  Frontiers in psychology 2014 Carhart-Harris R, Nutt D
• The entropic brain: a theory of conscious states informed by neuroimaging research with psychedelic drugs.
  Frontiers in human neuroscience 2014 Carhart-Harris RL, Leech R, Hellyer PJ, Shanahan M, Feilding A, Tagliazucchi E, Chialvo DR, Nutt D
• The Effects of Acutely Administered 3,4-Methylenedioxymethamphetamine on Spontaneous Brain Function in Healthy Volunteers Measured with Arterial Spin Labeling and Blood Oxygen Level-Dependent Resting State Functional Connectivity.
  Biological psychiatry 2014 Carhart-Harris RL, Murphy K, Leech R, Erritzoe D, Wall MB, Ferguson B, Williams LT, Roseman L, Brugger S, De Meer I, Tanner M, Tyacke R, Wolff K, Sethi A, Bloomfield MA, Williams TM, Bolstridge M, …
• A qualitative report on the subjective experience of intravenous psilocybin administered in an FMRI environment.
  Current drug abuse reviews 2014 Turton S, Nutt DJ, Carhart-Harris RL
• The effect of acutely administered MDMA on subjective and BOLD-fMRI responses to favourite and worst autobiographical memories.
  The international journal of neuropsychopharmacology 2013 Carhart-Harris RL, Wall MB, Erritzoe D, Kaelen M, Ferguson B, De Meer I, Tanner M, Bloomfield M, Williams TM, Bolstridge M, Stewart L, Morgan CJ, Newbould RD, Feilding A, Curran HV, Nutt DJ
• Broadband cortical desynchronization underlies the human psychedelic state.
  The Journal of neuroscience : the official journal of the Society for Neuroscience 2013 Muthukumaraswamy SD, Carhart-Harris RL, Moran RJ, Brookes MJ, Williams TM, Errtizoe D, Sessa B, Papadopoulos A, Bolstridge M, Singh KD, Feilding A, Friston KJ, Nutt DJ
• Experienced drug users assess the relative harms and benefits of drugs: a web-based survey.
  Journal of psychoactive drugs 2013 Carhart-Harris RL, Nutt DJ
• Psychiatry's next top model: cause for a re-think on drug models of psychosis and other psychiatric disorders.
  Journal of psychopharmacology (Oxford, England) 2013 Carhart-Harris RL, Brugger S, Nutt DJ, Stone JM
• Functional connectivity measures after psilocybin inform a novel hypothesis of early psychosis.
  Schizophrenia bulletin 2012 Carhart-Harris RL, Leech R, Erritzoe D, Williams TM, Stone JM, Evans J, Sharp DJ, Feilding A, Wise RG, Nutt DJ
• Implications for psychedelic-assisted psychotherapy: functional magnetic resonance imaging study with psilocybin.
  The British journal of psychiatry : the journal of mental science 2012 Carhart-Harris RL, Leech R, Williams TM, Erritzoe D, Abbasi N, Bargiotas T, Hobden P, Sharp DJ, Evans J, Feilding A, Wise RG, Nutt DJ
• Neural correlates of the psychedelic state as determined by fMRI studies with psilocybin.
  Proceedings of the National Academy of Sciences of the United States of America 2012 Carhart-Harris RL, Erritzoe D, Williams T, Stone JM, Reed LJ, Colasanti A, Tyacke RJ, Leech R, Malizia AL, Murphy K, Hobden P, Evans J, Feilding A, Wise RG, Nutt DJ
• A web-based survey on mephedrone.
  Drug and alcohol dependence 2011 Carhart-Harris RL, King LA, Nutt DJ
• The administration of psilocybin to healthy, hallucinogen-experienced volunteers in a mock-functional magnetic resonance imaging environment: a preliminary investigation of tolerability.
  Journal of psychopharmacology (Oxford, England) 2010 Carhart-Harris RL, Williams TM, Sessa B, Tyacke RJ, Rich AS, Feilding A, Nutt DJ
• The default-mode, ego-functions and free-energy: a neurobiological account of Freudian ideas.
  Brain : a journal of neurology 2010 Carhart-Harris RL, Friston KJ
• Equivalent effects of acute tryptophan depletion on REM sleep in ecstasy users and controls.
  Psychopharmacology 2009 Carhart-Harris RL, Nutt DJ, Munafo MR, Christmas DM, Wilson SJ
• Mourning and melancholia revisited: correspondences between principles of Freudian metapsychology and empirical findings in neuropsychiatry.
  Annals of general psychiatry 2008 Carhart-Harris RL, Mayberg HS, Malizia AL, Nutt D
• Current and former ecstasy users report different sleep to matched controls: a web-based questionnaire study.
  Journal of psychopharmacology (Oxford, England) 2008 Carhart-Harris RL, Nutt DJ, Munafò M, Wilson SJ